StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
IDYA

IDEAYA Biosciences, Inc.

IDYA Nasdaq Pharmaceutical Preparations EDGAR ↗
$35.40
-1.00 -2.75%

Key statistics

from XBRL data in SEC filings
Market cap
$3.11B
Revenue (TTM)
$219M
Net income (TTM)
-$140M
EPS (TTM)
$-1.57
P/E ratio
Dividend yield
Free cash flow
-$73.5M
Cash
$158M
Total assets
$1.03B
Gross margin
52-week range
$22.09 – $40.58

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results; Other events Jun 23, 2026 8-K Other events Jun 10, 2026 8-K Other events Jun 3, 2026 8-K Regulation FD disclosure; Other events Jun 1, 2026 8-K Other events May 5, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Other events Apr 13, 2026 8-K Other events Apr 9, 2026 10-K Fiscal year ended 2025-12-31 Feb 17, 2026 8-K Results of operations (earnings release) Feb 17, 2026 8-K Other events Jan 12, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Terminated a material agreement Dec 12, 2025 8-K Other events Dec 5, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Other events Oct 20, 2025 8-K Other events Sep 8, 2025 8-K Entered a material agreement Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Director or officer change Jun 27, 2025 8-K Shareholder vote results Jun 24, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Director or officer change Apr 2, 2025 10-K Fiscal year ended 2024-12-31 Feb 18, 2025 8-K Results of operations (earnings release) Feb 13, 2025 8-K Director or officer change Feb 10, 2025 8-K Entered a material agreement Dec 30, 2024 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release) Nov 4, 2024 8-K Other events Oct 25, 2024 8-K Other events Oct 4, 2024 8-K Other events Sep 23, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 10-Q/A Quarter ended 2024-03-31 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Entered a material agreement Jul 31, 2024